Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

NCT06690398 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritability Associated With Autism Spectrum Disorder

Interventions

DRUG: Lumateperone high dose
DRUG: Lumateperone low dose
DRUG: Placebo

Sponsor

Intra-Cellular Therapies, Inc.